Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07089953

Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomized Controlled Trial (EHR Study #3)

To learn about how patients view a doctor's compassion, communication skills, and professionalism based on whether the doctor uses the Electronic Health Record (EHR) during a visit with a patient.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location contact

Ali Haider, MD

CONTACT

[email protected]

713-563-9844

Ali Haider, MD

PRINCIPAL_INVESTIGATOR

About this study

Primary Objectives 1. To compare participants' perception of physicians' compassion after they watch two scripted-video vignettes of physicians: one portraying a traditional face to face clinical visit without the use of examination room computer, and the other one portraying a physician using an integrated model of EHR use for communication during the visit.

Secondary Objectives

  • Study To compare participants' perception of physicians' communication skills after they watch two scripted-video vignettes of physicians: one portraying a traditional face to face clinical visit without examination room computer use, and the other one portraying a physician using an integrated model of EHR use during communication.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Eligibility Criteria

  • Participants with a diagnosis of cancer either early disease or advanced cancer defined as locally advanced, recurrent, or metastatic disease.
  • Outparticipants (either new referrals or follow-ups) seen in the Supportive Care Clinic.
  • Age >/= 18 years old.
  • Able to read, write, and speak English.
  • Participants with normal cognitive status (Memorial Delirium Assessment Scale (MDAS) </= 6/30) who can understand the nature and purpose of the study and have the ability to complete the consent process.

Exclusion criteria

  • Participants who are experiencing severe symptom distress, including severe emotional distress, which may interfere with study participation. This will be measured by the Edmonton Symptom Assessment Scale (ESAS). Eligibility of participants with ESAS score >/= 7 on any item will be determined by the principal investigator and/or attending physician who is caring for the patient during that visit.
  • Participants with cognitive dysfunction (Memorial Delirium Assessment Scale (MDAS) >/= 7/30 will be excluded from the study.

Treatment and study plan

Questionnaire

Other

Complete 3 questionnaires about your emotions and your trust in doctors.

Other names: Questionnaires/Survey Measures

video

Other

Four (4) videos, each 4 minutes long, have been made for use in this study.

Primary outcomes

  1. Questionnaires/Videos

    Time frame: Through study completion; an average of 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Ali Haider, MD

CONTACT

[email protected]

713-563-9844

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2028
First posted
Jul 29, 2025
Registry last updated
Feb 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.